(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

DR.LOGES

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

DR.LOGES

ST13

US500000079284407

Classe

5

Pedido

79284407

Registro

6391774

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

38

Atualização mais recente

23/06/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5

Data de depósito

06/12/2019

Data de registro

22/06/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

22/06/2021

Última transação

23/06/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

16

Localização do titular

DE

Examinador

GALANTE, JOSHUA MICHAEL

Unidade examinadora

N90

Localização atual

TMO LAW OFFICE 127

Titulares e representantes

Titulares

Dr. Loges + Co. GmbH

Representantes

Robert S. Broder Collard & Roe, P.C.

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical anti-allergic preparations and substances; Pharmaceuticalveterinaryhealthcare preparationsfood supplements containing amino acidspreparations for the treatment of allergiesatherosclerosisarthritisarthrosisblood pressureblood fat levelsblood vesselsdepressive moodblood circulation disordersdiarrheainflammationerectile dysfunctioncoldmusculoskeletal conditionsbone and joint conditionsgoutflushinglescordialhay feverlumbagohot flashescoughssciaticalivermental performancefatigue and exhaustionmental fatigueneuralgianervousness and anxietyosteoporosisrheumatismthyroidsleeping disorderrhinitisstressdigestionforgetfulnessmenopausegastrointestinal conditionscardiovascular systempreparations for supporting the immune systemcholesterol metabolismmental and physical vitalitymental acuity and cognitionphysical energy balancephysical strength and endurancesexual performancemuscle cellsregeneration and healing of the bodypreparations for improving the results of physical training; Medicines for intestinal disorders; Balanced dietary foodstuffs adapted for medical usevitamins and mineral supplements containing trace elements and plant extract parts; Dietetic substances adapted for medical purposes and healthcare in the form of dietetic food products; Dietetic substances adapted for medical purposes and healthcarevitamins and mineral supplements containing trace elements and plant extract parts for pharmaceutical purposes; Non-medical dietary foodstuffsdietary supplements in the nature of vitamins and mineral supplements containing trace elements; Food supplements for medical purposes and healthcarevitamins and mineral supplements containing trace elements and plant extract parts for pharmaceutical purposes; balanced dietetic productsdietetic beverages adapted for medical purposes; Food supplements for non-medical purposes and healthcarevitamins and mineral supplements containing trace elements and plant extract parts for pharmaceutical purposes; Non-medical food supplements in the nature of vitaminsmineral supplementsmineral nutriments in the nature of dietary supplements containing trace elements and pro-vitamins; dietetic beverages for babies adapted for medical purposes; Meal replacement beverages adapted for medical purposes; beverages powdered being food supplements; bouillons for bacteriological cultures; Depuratives for the body; Veterinary preparationsantioxidants

Publicações

Histórico de despachos e eventos da marca no USPTO.

38 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

22/06/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/04/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/04/2023

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

07/04/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/04/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/04/2023

PRAM

POST REGISTRATION ACTION MAILED - SEC. 7

26/07/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/04/2022

WDRL

OTQR WITHDRAWAL FROM PUBLICATION

11/04/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/04/2022

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

09/03/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/03/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/11/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/10/2021

FIMP

FINAL DISPOSITION PROCESSED

09/10/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

22/09/2021

ES7R

TEAS SECTION 7 REQUEST RECEIVED

06/08/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

22/06/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/04/2021

PUBO

PUBLISHED FOR OPPOSITION

06/04/2021

GPNX

NOTIFICATION PROCESSED BY IB

05/04/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

17/03/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

17/03/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

17/03/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/03/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

26/02/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

26/02/2021

ALIE

ASSIGNED TO LIE

25/02/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

25/11/2020

RFNT

REFUSAL PROCESSED BY IB

12/06/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

27/05/2020

RFRR

REFUSAL PROCESSED BY MPU

27/05/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/05/2020

CNRT

NON-FINAL ACTION WRITTEN

06/05/2020

MAFR

APPLICATION FILING RECEIPT MAILED

05/05/2020

DOCK

ASSIGNED TO EXAMINER

01/05/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/05/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

30/04/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace DR.LOGES ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.